ArticleBMC ecology and evolution2026
Enhanced petroleum hydrocarbon degradation by biosurfactant-producing bacteria from Iko River estuarine sediments, Akwa Ibom State, Nigeria.
Article in BMC ecology and evolution, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydrocarbon contamination of estuaries poses a major environmental concern because of persistence and ecological toxicity, while nutrient availability often limit natural attenuation by indigenous microorganisms. This study evaluated the effects of glucose and sucrose biostimulation on petroleum hydrocarbon degradation by biosurfactant-producing bacteria from Iko River estuarine sediments, Akwa Ibom State, Nigeria, using standard physicochemical and microbiological techniques. Heavy metal concentrations of iron (1.43 mg/kg), vanadium (1.74 mg/kg), zinc (3.28 mg/kg), lead (3.01 mg/kg), cobalt (0.09 mg/kg), and nickel (0.43 mg/kg) were below sediment quality guideline thresholds. The mean heterotrophic bacterial abundance was 5.57 ± 0.9 log₁₀ CFU/g, which was 2.34 times higher than the 2.38 log₁₀ CFU/g recorded for hydrocarbonoclastic bacteria. Molecular characterization identified the isolates as Bacillus subtilis (MH145363.1), Pseudomonas aeruginosa (MZ299002.1), Bacillus cereus (AJ277908.1), Micrococcus luteus (OP848034.1), and Bacillus luti (CP040336.1), showing 99.72-100% similarity to GenBank reference strains. Pseudomonas aeruginosa exhibited 64% emulsification activity and reduced surface tension to 31.2 mN/m, indicating strong biodegradation potential. Glucose supplementation increased bacterial growth, with optical density ranging from 0.15 to 1.17 at 20% glucose by days 30-40, compared to 0.10-0.20 in the control, suggesting strong stimulation of microbial proliferation. Sucrose also enhanced growth, with optical density ranging from 0.38 ± 0.01 to 1.01 ± 0.02 at 20% sucrose by day 50, compared with 0.15 ± 0.02 to 0.20 ± 0.02 in the control. Glucose stimulation at 15% improved the abundance of Pseudomonas aeruginosa, with values ranging from 5.30 ± 0.92 to 5.74 ± 0.62 log₁₀ CFU/mL by day 50, while the unstimulated control declined to 3.94 ± 0.45 log₁₀ CFU/mL at the same time point, indicating nutrient limitation. Sugar amendment enhanced hydrocarbon degradation, with the highest efficiency observed at 10% glucose, recording 59.56%, followed by 5% and 15% glucose at 57.13% and 55.03% respectively, compared to 31.11% in the control. Sucrose treatments also improved degradation, with values ranging from approximately 50% to 67%, although no clear concentration-dependent trend was observed. Simple sugar biostimulation enhanced microbial growth and hydrocarbon degradation, highlighting a cost-effective and environmentally sustainable strategy for the bioremediation of hydrocarbon-impacted estuarine environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.